Dr. Dennis E. Hruby Net Worth

The estimated Net Worth of Dennis E Hruby is at least $4.19 Миллион dollars as of 1 July 2024. Dr Hruby owns over 32,258 units of SIGA Technologies Inc stock worth over $1,349,720 and over the last 20 years he sold SIGA stock worth over $1,370,250. In addition, he makes $1,466,772 as Exec. VP & Chief Scientific Officer at SIGA Technologies Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Dr Hruby SIGA stock SEC Form 4 insiders trading

Dr has made over 13 trades of the SIGA Technologies Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 32,258 units of SIGA stock worth $242,258 on 1 July 2024.

The largest trade he's ever made was exercising 300,000 units of SIGA Technologies Inc stock on 19 May 2011 worth over $750,000. On average, Dr trades about 44,417 units every 226 days since 2004. As of 1 July 2024 he still owns at least 179,723 units of SIGA Technologies Inc stock.

You can see the complete history of Dr Hruby stock trades at the bottom of the page.

Dr. Dennis E. Hruby biography

Dr. Dennis E. Hruby is the Exec. VP & Chief Scientific Officer at SIGA Technologies Inc.

What is the salary of Dr Hruby?

As the Exec. VP & Chief Scientific Officer of SIGA Technologies Inc, the total compensation of Dr Hruby at SIGA Technologies Inc is $1,466,772. There are 4 executives at SIGA Technologies Inc getting paid more, with Daniel Luckshire having the highest compensation of $1,684,000.

How old is Dr Hruby?

Dr Hruby is 69, he's been the Exec. VP & Chief Scientific Officer of SIGA Technologies Inc since . There are 2 older and 9 younger executives at SIGA Technologies Inc. The oldest executive at SIGA Technologies Inc is Thomas Constance, 83, who is the Independent Director.

What's Dr Hruby's mailing address?

Dennis's mailing address filed with the SEC is C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK, NY, 10065.

Insiders trading at SIGA Technologies Inc

Over the last 21 years, insiders at SIGA Technologies Inc have traded over $65,185,125 worth of SIGA Technologies Inc stock and bought 6,065,626 units worth $33,817,674 . The most active insiders traders include Holdings Incperelman Ronald..., Pharma Inc Transtech и Adnan M M Mjalli. On average, SIGA Technologies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $1,122,865. The most recent stock trade was executed by Dennis E Hruby on 1 July 2024, trading 32,258 units of SIGA stock currently worth $242,258.

What does SIGA Technologies Inc do?

at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.

Complete history of Dr Hruby stock trades at SIGA Technologies Inc

SIGA Technologies Inc executives and stock owners

SIGA Technologies Inc executives and other stock owners filed with the SEC include:

• Daniel Luckshire,
  Chief Financial Officer, Executive Vice President, Secretary
• Dr. Phillip Louis Gomez III, M.D., Ph.D.,
  CEO & Director
• Phillip Gomez,
  Chief Executive Officer, Director
• Robin Abrams,
  Chief Administrative Officer, General Counsel
• Dr. Dennis E. Hruby,
  Exec. VP & Chief Scientific Officer
• Dennis Hruby,
  Chief Scientific Officer, Vice President
• Daniel J. Luckshire,
  Exec. VP, CFO & Sec.
• Robin E. Abrams,
  Gen. Counsel & Chief Admin. Officer
• Eric Rose,
  Chairman of the Board
• Julie Kane,
  Independent Director
• Michael Plansky,
  Independent Director
• Joseph Marshall,
  Independent Director
• James Antal,
  Independent Director
• Thomas Constance,
  Independent Director
• Herb Vloedman,
  Chief Information Officer
• Tove C. Bolken,
  Sr. VP of Operations & Chief Supply Chain Officer
• Diem Nguyen,
  Chief Executive Officer
• Larry R. Miller,
  General Counsel
• Holdings Incperelman Ronald...,
  
• Bruce Slovin,
  Director
• Paul G Savas,
  
• Jeffrey B Kindler,
  
• Scott M Hammer,
  Director
• Donald G Drapkin,
  Director
• Bernard L Kasten,
  Chief Executive Officer
• Ayelet Dugary,
  Acting Chief Financial Officer
• Judy S Slotkin,
  Director
• Michael Md Weiner,
  Director
• Thomas N Konatich,
  CFO, Secretary and Treasurer
• Adnan M M Mjalli,
  Director
• John Odden,
  VP - Business Development
• Ronald O Mac Andrews & Forb...,
  
• William C Bevins,
  Director
• Susan K Burgess,
  President
• Michael J Bayer,
  Director
• Frances F Townsend,
  Director
• William J Ii Haynes,
  Executive VP & General Counsel
• Steven L Fasman,
  Director
• Pharma Inc Transtech,
  10% owner
• & Forbes Holdings Inc.Perel...,
  
• Mehmet C Md Oz,
  Director
• Donald G Drapkin,
  Director
• Evan A. Knisely,
  
• Edward P. Taibi,
  
• Holly L. Phillips,
  
• Jaymie A Durnan,
  
• Gary J. Nabel,
  
• Julian Nemirovsky,
  
• Harold Eugene Jr. Ford,
  
• Jay Varma,
  EVP & Chief Medical Officer